Newsletter - October 15, 2020
FDA Expects the Pandemic to Create Opportunity to Improve Cancer Trials
The pandemic has created unprecedented disruption in all cancer clinical trials but has also forced the sponsors to explore alternate ways to conduct their trials which could have long term positive effects on such trials much after the pandemic, opine FDA’s top experts in an article in the Journal of American Medical Association....Read More
Covid Vaccine Trials Highlight the Challenges to Recruit Minorities
Inclusion of minorities in Covid vaccine clinical trials is crucial to assure that the vaccine works across racial and ethnic populations but despite the keen interest in Covid vaccines, minorities represent a minor fraction of the trial participants. Companies have had mixed experience recruiting trial participants at educational institutions....Read More
FDA Expects the Pandemic to Create Opportunity to Improve Cancer Trials
The pandemic has created unprecedented disruption in all cancer clinical trials but has also forced the sponsors to explore alternate ways to conduct their trials which could have long term positive effects on such trials much after the pandemic, opine FDA’s top experts in an article in the Journal of American Medical Association....Read More
Covid Vaccine Trials Highlight the Challenges to Recruit Minorities
Inclusion of minorities in Covid vaccine clinical trials is crucial to assure that the vaccine works across racial and ethnic populations but despite the keen interest in Covid vaccines, minorities represent a minor fraction of the trial participants. Companies have had mixed experience recruiting trial participants at educational institutions....Read More
